Australia Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery
GlobalDatas new report, "Australia Diabetes Care Devices Market Outlook to 2022", provides key market data on the Australia Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
- Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Diabetes Care Devices market.
- Global corporate-level profiles of key companies operating within the Australia Diabetes Care Devices market.
- Key players covered include Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.